Literature DB >> 20980012

Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection.

Michael E Hadwiger1, Michael L Trehy, Wei Ye, Terry Moore, James Allgire, Benjamin Westenberger.   

Abstract

A high-pressure liquid chromatography-diode array detection and multi-mode ionization tandem mass spectrometry (HPLC-DAD-MMI-MS/MS) method was used to identify amino-tadalafil and rimonabant in electronic cigarette (e-cigarette) cartridges. Amino-tadalafil is a drug analogue of the commercially approved Cialis™ (i.e. tadalafil). Rimonabant is a drug that was, at one time, approved for weight loss in Europe (although approval has been retracted), but not in the United States. In addition, poor quality control over the e-cigarette products analyzed here is shown by the presence of nicotine in products labeled as containing no nicotine or by the presence of significant amounts of rimonabant oxidative degradant in e-cigarette products containing rimonabant. Identification was accomplished by comparing the retention time of relevant peaks in the sample with those of standard compounds, in addition to comparison of the UV spectra, mass spectra and/or product ion mass spectra. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980012     DOI: 10.1016/j.chroma.2010.10.018

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  33 in total

Review 1.  The electronic cigarette: a wolf in sheep's clothing.

Authors:  Manfred Neuberger
Journal:  Wien Klin Wochenschr       Date:  2015-05       Impact factor: 1.704

2.  E-cigarette use among Serbian adults: prevalence and user characteristics.

Authors:  Biljana Kilibarda; Viktor Mravcik; Marcus Sebastian Martens
Journal:  Int J Public Health       Date:  2016-01-29       Impact factor: 3.380

3.  Electronic nicotine delivery systems: a research agenda.

Authors:  Jean-François Etter; Chris Bullen; Andreas D Flouris; Murray Laugesen; Thomas Eissenberg
Journal:  Tob Control       Date:  2011-03-17       Impact factor: 7.552

Review 4.  Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review.

Authors:  Konstantinos E Farsalinos; Riccardo Polosa
Journal:  Ther Adv Drug Saf       Date:  2014-04

Review 5.  E-cigarettes--prevention, pulmonary health, and addiction.

Authors:  Dennis Nowak; Rudolf A Jörres; Tobias Rüther
Journal:  Dtsch Arztebl Int       Date:  2014-05-16       Impact factor: 5.594

Review 6.  In Vitro Models, Standards, and Experimental Methods for Tobacco Products.

Authors:  T Aghaloo; J J Kim; T Gordon; H P Behrsing
Journal:  Adv Dent Res       Date:  2019-10

7.  Clinical Laboratory Evaluation of Electronic Cigarettes/Electronic Nicotine Delivery Systems: Methodological Challenges.

Authors:  Melissa D Blank; Alison B Breland; Caroline O Cobb; Tory Spindle; Carolina Ramôa; Thomas Eissenberg
Journal:  Tob Regul Sci       Date:  2016-10

Review 8.  Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review.

Authors:  Jessica K Pepper; Noel T Brewer
Journal:  Tob Control       Date:  2013-11-20       Impact factor: 7.552

Review 9.  Science and electronic cigarettes: current data, future needs.

Authors:  Alison B Breland; Tory Spindle; Michael Weaver; Thomas Eissenberg
Journal:  J Addict Med       Date:  2014 Jul-Aug       Impact factor: 3.702

Review 10.  Electronic nicotine delivery systems ("e-cigarettes"): review of safety and smoking cessation efficacy.

Authors:  Paul Truman Harrell; Vani Nath Simmons; John Bernard Correa; Tapan Ashvin Padhya; Thomas Henry Brandon
Journal:  Otolaryngol Head Neck Surg       Date:  2014-06-04       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.